Finalist for Innovation of the Year in the Health & Wellness Programme category at the 13th Asia Pacific Eldercare Innovation Awards 2025
- Black Group Investment Holding
- Apr 10
- 1 min read
Black Group Investment Holding Pte Ltd, Singapore, is proud to announce that our NeuroAgeing Stem Cell-Derived Exosomes Therapy has received Special Recognition as a Finalist for Innovation of the Year in the Health & Wellness Programme category at the 13th Asia Pacific Eldercare Innovation Awards 2025! 🧠✨
This recognition was received by Mr. Zi Jing Tan, CEO of Black Group Investment Holding, during the prestigious World Ageing Festival 2025 held at Marina Bay Sands, Singapore.
The award celebrates innovation that advances the future of eldercare, and this milestone affirms Black Group’s commitment to redefining longevity and enhancing the quality of life through cutting-edge biotechnology. Our heartfelt gratitude to the organisers, judges, and partners who continue to champion innovation in eldercare across the region. ☺️
